Aug 12, 2021 / 07:30AM GMT
Operator
Ladies and gentlemen, welcome to the BioGaia Q2 report 2021. Today, I am pleased to present CEO, Isabelle Ducellier; and CFO, Alexander Kotsinas. (Operator Instructions)
Speakers, please begin.
Isabelle Valerie Ghislaine Ducellier - BioGaia AB(publ)-CEO&President
Thank you for the introduction, and welcome back from holiday or I hope you are on your holiday, you're still on holiday. So welcome to our interim management statement Q2 2021. In terms of net sales, we have a weak Q2 and for different reasons. The first one is that last year, we had our customer who order to prepare prior to the pandemic and wanted to make sure that the probiotics in their warehouse. So we had an extremely strong Q2 last year. So that's the first reason.
The second reason is that Q1 2021, we had a lot of orders that were planned to be delivered in Q2 that have been shipped with the last week of Q1 and mainly to China, which make that our Q1 were particularly good.
And I would say the last reason is the
Q2 2021 Biogaia AB Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot